November 9th 2026

By Ailsa Colquhoun

England & Wales: retrospective pricing adjustments

Nine products will be granted upward retrospective pricing adjustments, Community Pharmacy England has advised.

This is because the manufacturer did not update their product NHS list prices on the NHS dictionary of medicines and devices (dm+d) when the new list price changes took effect in 2026.

 The table below outlines the price adjustments for the affected products:

Product Actual list price Incorrect list price Price adjustment Adjusted for prescriptions dispensed between
Aveeno® cream (Kenvue UK Ltd) 100 ml £4.81 £4.25 £0.56 April to August 2026
Aveeno® cream (Kenvue UK Ltd) 300 ml £8.74 £8.56 £0.18 April to August 2026
Aveeno® cream (Kenvue UK Ltd) 500 ml £7.87 £7.59 £0.28 April to August 2026
metaX® low protein lemon wafers (metaX Institut fuer Diaetetik GmbH) 100 gram £5.85 £5.65 £0.20 August 2026
XPhe® minis tablets (metaX Institut fuer Diaetetik GmbH) 720 tablet 30 x 24 tablets £177.00 £170.35 £6.65 August 2026
Pro D3® 30,000unit capsules (Synergy Biologics Ltd) 10 capsule £24.99 £12.00 £12.99 August 2026
K.Yo® semi-solid food 100g pots berry (Vitaflo International Ltd) 4 pot £38.81 £37.16 £1.65 October 2026
K.Yo® semi-solid food 100g pots berry (Vitaflo International Ltd) 36 pot £262.04 £250.88 £11.16 October 2026
PKU express plus15® powder 25g sachets raspberry (Vitaflo International Ltd) 30 sachet £323.52 £309.74 £13.78 October 2026

NHSBSA is in the process of re-pricing generic and branded prescriptions (EPS and paper) for the affected products and will apply any upward price adjustments to payments received by affected contractors. NHSBSA will write to advise affected practices of any adjustments and in which payment schedules these will appear.


Latest news


Follow us


ad1 Follow us
ad1 Follow us
ad1 Follow @TheDDA1 on X